A Multicenter, Prospective, Cohort Study Examining the Incidence of Metachronous Cancer in Other Organs According to the Grade of Lugol-voiding lesion (LVL) after Curative Endoscopic Resection of Early Esophageal Cancer
Not Applicable
Recruiting
- Conditions
- Esophageal squamous cell carcinoma
- Registration Number
- JPRN-UMIN000018608
- Lead Sponsor
- AMED
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 385
Inclusion Criteria
Not provided
Exclusion Criteria
1) Registration in the JEC-1 study 2) A history of chemotherapy (including molecular targeted therapies) 3) A history of radiotherapy or surgical resection for head and neck cancer or esophageal cancer 4) Active double cancers in other organs (However, intramucosal cancers of other organs are not regarded to be active cancers in other organs.) 5) An allergy to iodine 6) Patients considered by their attending physicians to be unsuitable for enrollment in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method